(Total Views: 412)
Posted On: 07/07/2025 9:37:44 AM
Post# of 155188
Why would an ICI mfgr spend let's say $100m + to partner with Cytodyn, when prescriptions are physcician choice & a drug like Keytruda is few yrs from off patent ??
Inital thought was ICI pays to have a LL / ICI combo on file @ FDA
But ICI's are already approved.
Why wouldn't an ICI just run small LL/ICI combo on their own --- even Ai modeling...instead of $$$ to Cytodyn ??
I can think of 2 easy ways for Cytodyn future revenues
Cytodyn get's a % of mfgr sales site & CTC testing sales. Just can convince myself on big ICI direct funding per say
Inital thought was ICI pays to have a LL / ICI combo on file @ FDA
But ICI's are already approved.
Why wouldn't an ICI just run small LL/ICI combo on their own --- even Ai modeling...instead of $$$ to Cytodyn ??
I can think of 2 easy ways for Cytodyn future revenues
Cytodyn get's a % of mfgr sales site & CTC testing sales. Just can convince myself on big ICI direct funding per say
(0)
(0)
